Big Picture Plus Analysis from a Small, Compact, and Versatile Benchtop SEM – The JSM-6000PLUS NeoScope from JEOL

FOR IMMEDIATE RELEASE CONTACT:Patricia Corkum, Marketing Manager978-536-2273 • pcorkum@jeol.com • www.jeolusa.com March 7, 2016 (Pittcon 2016, Atlanta, Georgia) — JEOL introduces a new benchtop SEM at Pittcon 2016: the JSM-6000Plus, the third generation of the popular NeoScope. The NeoScope delivers fast, high magnification electron microscopy with more functionality than typical benchtop SEMs. The JSM-6000Plus model offers... Read more

JEOL Celebrates 10 year anniversary of Direct Analysis in Real Time and Introduces New AccuTOF-DART 4G

FOR IMMEDIATE RELEASE CONTACT:Patricia Corkum, Marketing Manager978-536-2273 • pcorkum@jeol.com • www.jeolusa.com March 9, 2015 (Pittcon, New Orleans) — JEOL is proud to celebrate the 10th anniversary of the introduction of the enormously popular AccuTOF-DART® ambient ionization mass spectrometer by introducing the new AccuTOF-DART®4G at Pittcon 2015, with new performance capabilities including enhanced resolution, speed, and accuracy in... Read more

JEOL Unveils 4th Generation GCxGC Mass Spectrometer with Powerful Data Analysis Software at Pittcon 2015

FOR IMMEDIATE RELEASE CONTACT:Patricia Corkum, Marketing Manager978-536-2273 • pcorkum@jeol.com • www.jeolusa.com March 9, 2015 Peabody, MA — The JEOL AccuTOF-GCx will be exhibited for the first time in the U.S. at Pittcon 2015 in New Orleans, booth #1523. The AccuTOF-GCx, the fourth generation of JEOL’s successful gas chromatography/time-of-flight mass spectrometer systems, is designed for optimum throughput,... Read more

Analysis of Autofluorescence in Polymorphonuclear Neutrophils: A New Tool for Early Infection Diagnosis

Diagnosing bacterial infection (BI) remains a challenge for the attending physician. An ex vivo infection model based on human fixed polymorphonuclear neutrophils (PMNs) gives an autofluorescence signal that differs significantly between stimulated and unstimulated cells. We took advantage of this property for use in an in vivo pneumonia mouse model and in patients hospitalized with... Read more

JEOL Mass Spectrometry News for Pittcon 2014

March 3, 2014 (Pittcon, Chicago, IL) — The AccuTOF GCV 4G time-of-flight mass spectrometer that JEOL introduced at last year’s PittCon has received great interest from the mass spectrometry community. JEOL USA, Inc. has received several purchase orders from industrial and academic laboratories, with systems already delivered and installed in the US and Canada. In... Read more

JEOL and Zoex Partnership Combines Comprehensive Two-Dimensional Gas Chromatography with High Sensitivity Mass Spectrometer

(Peabody, Mass. June 7, 2013) — JEOL USA, Inc. (Peabody, MA) has concluded an OEM agreement with Zoex Corporation (Houston, TX) to offer the Zoex comprehensive two-dimensional gas chromatography (GC x GC) technology with the new JEOL AccuTOF GCV 4G high-resolution time-of-flight mass spectrometer system.  “We are very excited about the partnership with Zoex. The... Read more

JEOL High Sensitivity GC-TOF Increases Data Acquisition Speed and Mass Resolving Power

August 3, 2012 (Peabody, Mass.) – JEOL’s newest AccuTOF GCv model – the “4G” – now offers even faster data acquisition rates and higher resolving power than its predecessor. The AccuTOF-GCv|4G has a maximum data acquisition rate of 50 spectra per second and a resolving power of 8000. The 50 Hz acquisition rate now makes... Read more

New SpiralTOF™ MALDI TOF Applications Notebook Available from JEOL

July 26, 2012 (Peabody, Mass.) – A new Applications Notebook from JEOL features over 20 application notes describing the analysis of synthetic polymers, small organic molecules, complex drug mixtures, peptides, and proteins using the JEOL SpiralTOFTM MALDI TOF-TOF mass spectrometer. The SpiralTOF time-of-flight optics design utilizes a figure-eight ion trajectory to allow a 17m flight... Read more

JEOL AccuTOF-DART Mass Spectrometer Used in Georgia Institute of Technology’s Newly-Developed Ovarian Cancer Test

August 18, 2010 (Peabody, Mass.) — Called the silent killer, ovarian cancer is one of the most insidious and hardest to detect diseases. It is the leading cause of death from gynecologic cancers in the United States and, because it presents no obvious symptoms, it is often detected too late. Researchers at Georgia Institute of... Read more